Search research articles
Contact Us
Filters
Showing results (11-20 of 41) with videos related to
Page
of 5
Sort By:
Journal of Neuroimmunology
|
December 26, 2013
Killer immunoglobulin-like receptor and their HLA ligands in Guillain-Barré Syndrome
Stefan Blum, Peter Csurhes, Stephen Reddel, et al.
Journal of Neurodegenerative Diseases
|
August 29, 2015
The MFN2 V705I Variant Is Not a Disease-Causing Mutation: A Segregation Analysis in a CMT2 Family
Obaid M Albulym, Danqing Zhu, Stephen Reddel, et al.
BMJ Neurology Open
|
June 6, 2022
Refractory <i>Mycobacterium genavense</i> infection secondary to thymoma-associated endogenous IL-12 inhibitor
Jessie Chen, MaiAnh Nguyen, Elaine Cheong, et al.
American Journal of Medical Genetics. Part A
|
October 3, 2023
ACBD5-related retinal dystrophy with leukodystrophy due to novel mutations in ACBD5 and with additional features including ovarian insufficiency
Laura Ivete Rudaks, James Triplett, Katrina Morris, et al.
Practical Neurology
|
April 14, 2018
<i>Actinomyces</i> cavernous sinus infection: a case and systematic literature review
Michal Lubomski, James Dalgliesh, Kenneth Lee, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
May 30, 2015
Clinical features and impact of myasthenia gravis disease in Australian patients
Stefan Blum, David Lee, David Gillis, et al.
Practical Neurology
|
August 3, 2024
Immunoglobulin use in neurology: a practical approach
Mahima Kapoor, Anthony Khoo, Michael P T Lunn, et al.
Therapeutic Advances in Neurological Disorders
|
April 11, 2019
Risks and risk management in modern multiple sclerosis immunotherapeutic treatment
Luisa Klotz, Joachim Havla, Nicholas Schwab, et al.
Therapeutic Advances in Neurological Disorders
|
April 3, 2023
Comparison of IVIg and TPE efficacy in the treatment of neurological disorders: a systematic literature review
Ashwin A Pinto, Jerome De Seze, Anu Jacob, et al.
The Journal of Biological Chemistry
|
November 17, 2001
Heparin inhibits the binding of beta 2-glycoprotein I to phospholipids and promotes the plasmin-mediated inactivation of this blood protein. Elucidation of the consequences of the two biological events in patients with the anti-phospholipid syndrome
Jan Guerin, Yonghua Sheng, Stephen Reddel, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 41) with videos related to
Sort By:
Page
of 5
Journal of Neuroimmunology
|
December 26, 2013
Killer immunoglobulin-like receptor and their HLA ligands in Guillain-Barré Syndrome
Stefan Blum, Peter Csurhes, Stephen Reddel, et al.
Journal of Neurodegenerative Diseases
|
August 29, 2015
The MFN2 V705I Variant Is Not a Disease-Causing Mutation: A Segregation Analysis in a CMT2 Family
Obaid M Albulym, Danqing Zhu, Stephen Reddel, et al.
BMJ Neurology Open
|
June 6, 2022
Refractory <i>Mycobacterium genavense</i> infection secondary to thymoma-associated endogenous IL-12 inhibitor
Jessie Chen, MaiAnh Nguyen, Elaine Cheong, et al.
American Journal of Medical Genetics. Part A
|
October 3, 2023
ACBD5-related retinal dystrophy with leukodystrophy due to novel mutations in ACBD5 and with additional features including ovarian insufficiency
Laura Ivete Rudaks, James Triplett, Katrina Morris, et al.
Practical Neurology
|
April 14, 2018
<i>Actinomyces</i> cavernous sinus infection: a case and systematic literature review
Michal Lubomski, James Dalgliesh, Kenneth Lee, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
May 30, 2015
Clinical features and impact of myasthenia gravis disease in Australian patients
Stefan Blum, David Lee, David Gillis, et al.
Practical Neurology
|
August 3, 2024
Immunoglobulin use in neurology: a practical approach
Mahima Kapoor, Anthony Khoo, Michael P T Lunn, et al.
Therapeutic Advances in Neurological Disorders
|
April 11, 2019
Risks and risk management in modern multiple sclerosis immunotherapeutic treatment
Luisa Klotz, Joachim Havla, Nicholas Schwab, et al.
Therapeutic Advances in Neurological Disorders
|
April 3, 2023
Comparison of IVIg and TPE efficacy in the treatment of neurological disorders: a systematic literature review
Ashwin A Pinto, Jerome De Seze, Anu Jacob, et al.
The Journal of Biological Chemistry
|
November 17, 2001
Heparin inhibits the binding of beta 2-glycoprotein I to phospholipids and promotes the plasmin-mediated inactivation of this blood protein. Elucidation of the consequences of the two biological events in patients with the anti-phospholipid syndrome
Jan Guerin, Yonghua Sheng, Stephen Reddel, et al.
Page
of 5